Sort   by:  
 Page size 
UnknownDapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial.
Not available
S-EPMC7523621 | biostudies-literature
UnknownThe NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease.
Not available
S-EPMC7749353 | biostudies-literature
UnknownInterleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
Not available
S-EPMC8760628 | biostudies-literature
UnknownPancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment.
Not available
S-EPMC10510589 | biostudies-literature
UnknownStructural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.
Not available
S-EPMC15564 | biostudies-literature
UnknownEffects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.
Not available
S-EPMC3402269 | biostudies-literature
UnknownInterleukin-37 monomer is the active form for reducing innate immunity.
Not available
S-EPMC6431183 | biostudies-literature
UnknownCirculating interleukin-37 declines with aging in healthy humans: relations to healthspan indicators and IL37 gene SNPs.
Not available
S-EPMC9137444 | biostudies-literature
UnknownLeukocyte activity in patients with ST-segment elevation acute myocardial infarction treated with anakinra.
Not available
S-EPMC4277550 | biostudies-literature
UnknownIL-1 receptor antagonism reveals a yin-yang relationship between NFκB and interferon signaling in chronic lymphocytic leukemia.
Not available
S-EPMC11331101 | biostudies-literature
Sort   by:  
 Page size